Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

MRNSMRNS
16 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in MARINUS PHARMACEUTICALS INC

As of its Q4 2024 13F, Two Sigma held 22,868 shares of MRNS (Marinus Pharmaceuticals), worth $12,237. Two Sigma's 13F filings listed MRNS from Q3 2024 to Q4 2024, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$209,000

Total Shares Change

-16,301

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Decreased
22,868
-52.0%
$12,2370.0%—
0
2024-Q3
New
47,665
-
$83,8900.0%—
30
2024-Q2
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Increased
42,834
+4.0%
$387,2190.0%—
25
2023-Q4
Decreased
41,205
-23.8%
$447,8980.0%—
0
2023-Q3
Decreased
54,105
-75.7%
$435,5450.0%—
0
2023-Q2
New
222,484
-
$2.4M0.0%—
36
2022-Q3
Exited
0
-100.0%
$00.0%—
0
2022-Q2
Increased
51,325
+124.0%
$248,0000.0%—
37
2022-Q1
New
22,916
-
$214,0000.0%—
32
2021-Q3
Exited
0
-100.0%
$00.0%—
0
2021-Q2
Decreased
59,292
-1.0%
$1.1M0.0%—
0
2021-Q1
Decreased
59,868
-8.7%
$927,0000.0%—
0
2020-Q4
Increased
65,600
+302.4%
$800,0000.0%—
40
2020-Q3
New
16,301
-
$209,0000.0%—
32

Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used